Publication | Closed Access

Vasoactive intestinal peptide (VIP) induces c-fos expression in LNCaP prostate cancer cells through a mechanism that involves Ca2+ signalling. Implications in angiogenesis and neuroendocrine differentiation

Signal TransductionSignaling PathwayG Protein-coupled ReceptorPhysiologyNeuropeptide ReceptorNeuroendocrine DifferentiationVascular BiologyVasoactive Intestinal PeptideMedicineCell BiologyCell SignalingCellular PhysiologyTumor BiologyC-fos ExpressionGastrointestinal Peptide Hormone